Search results for 'Cadila Healthcare'

Diabetes medicines, antibiotics to now get cheaper in India

Diabetes medicines, antibiotics to now get cheaper in India

Rediff.com16 Jul 2015

Indian government has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics.

Zydus may set up US facility

Zydus may set up US facility

Rediff.com21 Jan 2005

Pharma industry's most wanted men

Pharma industry's most wanted men

Rediff.com29 Apr 2004

Govt waives import duty on Remdesivir

Govt waives import duty on Remdesivir

Rediff.com20 Apr 2021

This import duty exemption would remain in force till October 31 this year.

Govt clarifies over ICMR's Aug 15 deadline for Covid vaccine

Govt clarifies over ICMR's Aug 15 deadline for Covid vaccine

Rediff.com9 Jul 2020

'Please don't read something which is not there in DG, ICMR's letter. The intent of the letter is only to expedite duly approved clinical trials without compromising on security and safety concerns'

MNC pharma cos may be afflicted by pneumonia virus

MNC pharma cos may be afflicted by pneumonia virus

Rediff.com22 Apr 2019

Aurobindo Pharma, Cadila Healthcare and Serum Institute are readying their vaccine candidates.

Pharma stocks on a booster dose

Pharma stocks on a booster dose

Rediff.com1 Mar 2014

Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Phase-I trials of 2 Indian Covid vaccines reveal 'excellent safety': Govt

Rediff.com15 Sep 2020

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, minister of state for health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Sensex jumps 178 points; Nifty reclaims 10,600 level

Sensex jumps 178 points; Nifty reclaims 10,600 level

Rediff.com3 Jul 2020

Bharti Airtel was the top gainer in the Sensex pack, rallying around 4 per cent, followed by Bajaj Auto, TCS, Titan, HCL Tech and Reliance Industries. On the other hand, IndusInd Bank, Tata Steel and HDFC Bank were among the laggards.

Big drugmakers step in to develop, import test kits

Big drugmakers step in to develop, import test kits

Rediff.com20 Apr 2020

Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.

1 cr frontline healthcare workers identified to get Covid vaccine

1 cr frontline healthcare workers identified to get Covid vaccine

Rediff.com24 Nov 2020

Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.

India may ease clinical trial norms for coronavirus vaccine

India may ease clinical trial norms for coronavirus vaccine

Rediff.com1 Apr 2020

The Central Drugs Standard Control Organisation said while the rights, safety, and well-being of trial subjects were of paramount importance, protocol amendment, deviation or modification might be necessary in some cases owing to unavoidable circumstances.

5 FDI proposals worth Rs 6,050 crore get cleared

5 FDI proposals worth Rs 6,050 crore get cleared

Rediff.com14 Jan 2016

The FIPB rejected two proposals -- Nigeria's Mokeme Chiwetal Izuchukwu and Lanarth Developers Pvt Ltd.

Why US' revocation may not have much effect on HCQs exports

Why US' revocation may not have much effect on HCQs exports

Rediff.com17 Jun 2020

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis and autoimmune lupus.

4 Indian drug firms recall products in US market

4 Indian drug firms recall products in US market

Rediff.com15 Nov 2020

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Marksans Pharma is recalling diabetes drug, Zydus Pharmaceuticals (USA) is recalling drug which is used to reduce stomach acid. Similarly, Aurobindo Pharma (USA) is recalling pain relieving drug, while Jubilant Cadista is recalling a medication used to treat schizophrenia.

Why drug firms' Q2 revenue growth is likely to dip

Why drug firms' Q2 revenue growth is likely to dip

Rediff.com12 Oct 2018

Currency played an important role in Q2, with US dollar, Japanese yen and euro appreciating vis-a-vis the Indian rupee, while the Brazilian real, South African rand and Russian ruble depreciating against rupee.

Several dark patches in 2013's performing sectors

Several dark patches in 2013's performing sectors

Rediff.com31 Dec 2013

IT, pharma and FMCG stocks are the top performers in 2013.

36 drugs to be cheaper as govt caps prices

36 drugs to be cheaper as govt caps prices

Rediff.com19 Sep 2014

India has capped the prices of 36 drugs, including those used to treat infections and diabetes, in its latest move to make essential medicines more affordable, a senior official of the country's drug pricing authority told Reuters on Friday.

Why HRD ministry nixed all names for IIM-A chairman's post

Why HRD ministry nixed all names for IIM-A chairman's post

Rediff.com30 May 2016

This is reportedly the first time that the names recommended by a search committee have been shot down by the HRD ministry

3rd wave: Govt creating 30-day stock of key Covid medicines

3rd wave: Govt creating 30-day stock of key Covid medicines

Rediff.com26 Jul 2021

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What's better is that this time, the government is paying us in advance,' said a senior executive of a Mumbai-based pharma player which makes Remdesivir. Sohini Das reports.

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Cipla to price Remdesivir for Covid-19 under Rs 5,000

Rediff.com25 Jun 2020

Hetero has priced the injectable drug at Rs 5,400 per 100 mg vial. With More drugmakers in line to launch the drug soon, the prices may see a further erosion.

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Rediff.com4 Jan 2021

Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.

Pharma industry bounces back to good health

Pharma industry bounces back to good health

Rediff.com12 Jun 2018

In May, price growth for drugs was in negative territory at (-)1 per cent

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Corbevax cleared for kids in 5-12 yrs age group, Covaxin for 6-12

Rediff.com26 Apr 2022

The approval by the Drugs Controller General of India comes following recommendations by the Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation.

Covid drug sales shine even as market slows

Covid drug sales shine even as market slows

Rediff.com18 Aug 2020

Fabiflu sales have grown by 62 per cent in July. It was launched in June. This drug is being used by doctors for mild-to-moderate Covid patients even if they are in home isolation.

Indian drug cos to benefit as US expedites generic clearances

Indian drug cos to benefit as US expedites generic clearances

Rediff.com12 May 2014

Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.

Are You Eligible For A Booster Shot?

Are You Eligible For A Booster Shot?

Rediff.com27 Dec 2021

'Someone may have diabetes, but at what level the disease qualifies as a comorbid condition is something a doctor will decide upon and certify accordingly.'

ICMR aims to launch COVID-19 vaccine by Aug 15

ICMR aims to launch COVID-19 vaccine by Aug 15

Rediff.com3 Jul 2020

The vaccine candidate, ZyCoV-D, showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralise the wild type virus, Zydus said. The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.

Zydus infringed Takeda's patent, rules US court

Zydus infringed Takeda's patent, rules US court

Rediff.com20 Jun 2013

Takeda had filed a case of patent infringement in response to Zydus' abbreviated new drug application.

In the works: Priority list of who will get Covid vaccine first

In the works: Priority list of who will get Covid vaccine first

Rediff.com4 Sep 2020

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Human clinical trials for COVID-19 vaccine initiated in India: ICMR

Rediff.com14 Jul 2020

Since India is one of the largest vaccine producers in the world, it is the country's 'moral responsibility' to fast-track vaccine development process to break the chain of coronavirus transmission, ICMR Director General Dr Balram Bhargava said referring to the two vaccine candidates developed indigenously.

Can these stocks shine amid market gloom?

Can these stocks shine amid market gloom?

Rediff.com8 Mar 2018

Investors turn their attention to export-driven sectors.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

Traders seek Army's help to distribute medicines

Traders seek Army's help to distribute medicines

Rediff.com31 Mar 2020

The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.

ASK AJIT: How to get 20% return on shares?

ASK AJIT: How to get 20% return on shares?

Rediff.com17 Dec 2021

Ajit Mishra, vice president, research, Religare Broking, answers your queries.

Myanmar allows traffic rights to Indian airlines

Myanmar allows traffic rights to Indian airlines

Rediff.com10 Jun 2013

At present, there is no direct air connectivity between India and Myanmar.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

Shots of Covid vaccine to be taken 28 days apart: AIIMS chief

Shots of Covid vaccine to be taken 28 days apart: AIIMS chief

Rediff.com3 Jan 2021

In a video issued by the Health Ministry, Dr Randeep Guleria, Director of the All India Institute of Medical Sciences (AIIMS) answered commonly asked questions regarding the dosage of the vaccine saying that two doses of the vaccine will have to be taken 28 days apart and protective levels of antibodies generally would develop two weeks after the second dose.